Vaqta 1ml Im Vial (adults19+)
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
If you miss a dose, contact your doctor to receive guidance on what to do next.
Lifestyle & Tips
- Continue practicing good hygiene, especially handwashing, to prevent the spread of infections.
- No specific dietary restrictions or lifestyle changes are required due to the vaccine.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Seek Immediate Medical Attention If You Experience:
- Signs of a severe allergic reaction (anaphylaxis): difficulty breathing, wheezing, hives, swelling of the face or throat, dizziness, rapid heartbeat. Seek immediate medical attention.
- High fever (above 102°F or 39°C).
- Severe or persistent pain, redness, or swelling at the injection site that worsens over time.
- Unusual weakness or numbness.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any health problems you have, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
As with all vaccines, this vaccine may not provide complete protection against the disease for every individual who receives it. If you have any questions or concerns, discuss them with your doctor. Note that this vaccine will not protect you against other types of hepatitis.
This vaccine contains a non-active virus, which means it cannot cause the disease itself. However, if you have a weakened immune system or are taking medications that suppress the immune system, consult your doctor, as the vaccine may not be as effective.
If you are pregnant, planning to become pregnant, or are breastfeeding, inform your doctor. You will need to discuss the potential benefits and risks of the vaccine to both you and your baby to make an informed decision.
Overdose Information
Overdose Symptoms:
- Overdose with vaccines is not typically associated with specific toxic symptoms beyond exaggerated local or systemic reactions. No specific antidote.
What to Do:
In case of suspected overdose, monitor for adverse reactions and provide symptomatic and supportive care. Call 1-800-222-1222 (Poison Control) for advice if concerned.
Drug Interactions
Major Interactions
- Immunosuppressive therapies (e.g., corticosteroids, chemotherapy, radiation therapy): May reduce the immune response to the vaccine, leading to suboptimal protection.
Moderate Interactions
- Other vaccines: Can generally be co-administered with other inactivated vaccines and most live vaccines at different injection sites. Consult ACIP guidelines for specific co-administration recommendations.
Monitoring
Baseline Monitoring
Rationale: To identify contraindications or precautions and assess risk of adverse reactions or reduced vaccine efficacy.
Timing: Prior to vaccination
Routine Monitoring
Frequency: For at least 15 minutes post-vaccination
Target: Absence of severe allergic reactions
Action Threshold: Any signs of anaphylaxis (e.g., rash, swelling, difficulty breathing, hypotension) require immediate medical intervention.
Frequency: Within 24-48 hours post-vaccination
Target: Mild to moderate, self-limiting
Action Threshold: Severe or persistent reactions, or signs of infection, warrant medical evaluation.
Symptom Monitoring
- Injection site pain, redness, swelling
- Headache
- Fatigue
- Low-grade fever
- Nausea
- Loss of appetite
- Malaise
- Muscle aches
- Rash (rare, but monitor for allergic reactions)
Special Patient Groups
Pregnancy
Hepatitis A vaccine is generally considered safe during pregnancy. It is an inactivated vaccine, which typically poses no risk to the fetus. Vaccination is recommended for pregnant women who are at increased risk for HAV infection or severe outcomes from HAV infection (e.g., chronic liver disease, travel to endemic areas).
Trimester-Specific Risks:
Lactation
Hepatitis A vaccine is considered safe for breastfeeding mothers and their infants. It is an inactivated vaccine and does not pose a risk to the infant through breast milk.
Pediatric Use
The 1mL formulation of Vaqta is not indicated for pediatric use (individuals under 19 years of age). A 0.5mL formulation is available for pediatric and adolescent populations (12 months through 18 years of age).
Geriatric Use
No specific dose adjustment is required for geriatric patients. Immune response may be slightly lower in older adults compared to younger adults, but the vaccine is still effective and recommended for at-risk older adults.
Clinical Information
Clinical Pearls
- Vaqta 1mL vial is specifically for individuals 19 years of age and older. Ensure correct formulation (0.5mL vs 1mL) is used for the appropriate age group.
- Administer intramuscularly, preferably in the deltoid muscle.
- A booster dose 6-18 months after the primary dose is crucial for long-term protection.
- Can be co-administered with most other routine vaccines, but use separate injection sites and syringes.
- Patients with a history of severe allergic reaction to any component of the vaccine or to a previous dose are contraindicated.
- Immunocompromised individuals may have a diminished immune response to the vaccine; serologic testing post-vaccination may be considered in some cases to confirm adequate antibody response.
Alternative Therapies
- Havrix (Hepatitis A Vaccine, Inactivated)
- Twinrix (Hepatitis A and Hepatitis B Vaccine, Inactivated, combined)